SCHEMBL14559362

SCHEMBL14559362

CN1CCCC(CNC(=O)ON2C(=O)CCC2=O)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.37
▸ CHRNB2 P17787 1/20 0.36
▸ CHRNB4 P30926 1/20 0.36
▸ CHRNA3 P32297 1/20 0.36
▸ CHRNA4 P43681 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ DRD2 P14416 1/20 0.34
▸ DRD3 P35462 1/20 0.34
▸ SSTR4 P31391 2/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ MGLL Q99685 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30425794 0.85 MAPT (0.39) HDAC1HDAC2DRD2DRD3SSTR4
SCHEMBL9002622 0.83 EPHX1 (0.45) KMT2AHRH3
SCHEMBL14559369 0.80 CHRNB2 (0.39) CHRNB2CHRNA4DRD2DRD3
SCHEMBL21754480 0.80 SMN1; SMN2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL14559360 0.78 CHRNB2 (0.39) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL21754477 0.77 SMN1; SMN2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL14559359 0.76 MALT1 (0.39) CHRNB2CHRNA4
SCHEMBL10212235 0.75 DRD2 (0.46) KMT2ASMN1; SMN2DRD2ALDH1A1MEN1
SCHEMBL16020326 0.75 DRD2 (0.46) KMT2ASMN1; SMN2DRD2ALDH1A1MEN1
SCHEMBL16020332 0.75 DRD2 (0.46) KMT2ASMN1; SMN2DRD2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186739-B2 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas IMMUPHARMA (FRANCE) SA (FR) 2007-03-06 — — US disclosed
Send feedback